Clinical Trial Update: Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1" [Phase 2]

View source ↗

Summary

Phase 2 trial of ciprofloxacin for inhalation in patients with non-Cystic Fibrosis bronchiectasis completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Ciprofloxacin for inhalation (ciprofloxacin)

Snippet

Sponsor: Aradigm Corporation | Conditions: Non-Cystic Fibrosis Bronchiectasis | Phase 2 | Status: COMPLETED